The global flow imaging microscopy market is projected to reach USD 49.23 million in 2023 from USD 31.67 million in 2018, at a CAGR of 9.2%.

The advantages of flow imaging microscopy over particle size analyzers and the growing investment in pharmaceutical and biopharmaceutical R&D are expected to drive the growth of the market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=156876758

On the basis of sample type, the market is divided into biologics, small molecules, and other sample types (fillers and excipients). The biologics segment is expected to grow at the highest CAGR. As flow imaging microscopy helps in the direct image-based analysis of subvisible particles, it is widely adopted in biologics-based formulation development.

On the basis of end user, the global flow imaging microscopy market is divided into pharmaceutical, biotechnology companies, and other end users (CROs, CMOs, and academic institutes). In 2018, the other end user segment is expected to grow at the highest CAGR in the global flow imaging microscopy market. The adoption of flow imaging microscopy in CROs and CMOs is mainly driven by the increase in outsourcing of research and manufacturing services.

On the basis of sample dispersion, the global flow imaging microscopy market is divided into wet and dry dispersion. The wet dispersion segment is expected to grow at a higher CAGR. This growth can be attributed to the wide application of wet dispersion in biologics which are often in the liquid form.

The APAC market is projected to register the highest growth rate during the forecast period primarily due to factors such as investment opportunities in drug discovery & development for big pharmaceutical and biotechnology companies and the outsourcing of drug discovery and development activities to APAC-based CROs. With such huge growth opportunities, big players are focusing their expansion in emerging pharmaceutical markets such as China and India.